Polycyclic Aromatic Hydrocarbons Affect Rheumatoid Arthritis Pathogenesis

aryl hydrocarbon receptor aryl hydrocarbon receptor repressor particulate matter polycyclic aromatic hydrocarbons rheumatoid arthritis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 19 10 2021
accepted: 28 02 2022
entrez: 8 4 2022
pubmed: 9 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

Rheumatoid arthritis (RA), the most common autoimmune disease, is characterized by symmetrical synovial inflammation of multiple joints with the infiltration of pro-inflammatory immune cells and increased cytokines (CKs) levels. In the past few years, numerous studies have indicated that several factors could affect RA, such as mutations in susceptibility genes, epigenetic modifications, age, and race. Recently, environmental factors, particularly polycyclic aromatic hydrocarbons (PAHs), have attracted increasing attention in RA pathogenesis. Therefore, exploring the specific mechanisms of PAHs in RA is vitally critical. In this review, we summarize the recent progress in understanding the mechanisms of PAHs and aryl hydrocarbon receptors (AHRs) in RA. Additionally, the development of therapeutic drugs that target AHR is also reviewed. Finally, we discuss the challenges and perspectives on AHR application in the future.

Identifiants

pubmed: 35392076
doi: 10.3389/fimmu.2022.797815
pmc: PMC8981517
doi:

Substances chimiques

Polycyclic Aromatic Hydrocarbons 0
Receptors, Aryl Hydrocarbon 0

Types de publication

Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

797815

Informations de copyright

Copyright © 2022 Xi, Ye, Fan, Cao, Wang, Wang, Zhang, Xu and Xiao.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Clin Immunol. 2020 Feb;211:108342
pubmed: 31926330
J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96
pubmed: 16522681
Inflammation. 2017 Aug;40(4):1342-1350
pubmed: 28478516
Environ Int. 2016 Sep;94:495-499
pubmed: 27302847
Int Arch Occup Environ Health. 2003 Sep;76(7):533-8
pubmed: 12827370
Arthritis Rheum. 2002 Jul;46(7):1763-72
pubmed: 12124859
Environ Res. 2005 May;98(1):22-32
pubmed: 15721880
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19961-6
pubmed: 21041655
Arthritis Res Ther. 2018 Jun 8;20(1):119
pubmed: 29884199
Annu Rev Pharmacol Toxicol. 2000;40:519-61
pubmed: 10836146
Eur J Immunol. 2018 May;48(5):771-776
pubmed: 29336030
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8185-9
pubmed: 1325649
Calcif Tissue Int. 2013 Aug;93(2):121-32
pubmed: 23748710
Environ Pollut. 2019 Oct;253:1030-1037
pubmed: 31434180
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
J Biol Chem. 1995 Dec 8;270(49):29270-8
pubmed: 7493958
J Biol Chem. 1998 Jan 30;273(5):2895-904
pubmed: 9446600
Arthritis Rheumatol. 2020 Oct;72(10):1658-1667
pubmed: 32475073
Arthritis Rheum. 2011 Jan;63(1):73-83
pubmed: 20954258
Sci Total Environ. 2021 Sep 15;787:147596
pubmed: 33991922
Vaccine. 2010 Aug 31;28 Suppl 3:C2-13
pubmed: 20713253
Cell Mol Life Sci. 2020 Apr;77(7):1387-1399
pubmed: 31342120
Toxicol Sci. 2011 Mar;120 Suppl 1:S171-91
pubmed: 20952503
Environ Health Perspect. 2009 Jul;117(7):1065-9
pubmed: 19654914
Environ Res. 2019 Jun;173:306-317
pubmed: 30951957
Toxicol Sci. 2014 Jan;137(1):114-24
pubmed: 24154488
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9721-6
pubmed: 18607004
J Proteome Res. 2015 Jan 2;14(1):164-82
pubmed: 25362887
Nature. 2008 May 1;453(7191):65-71
pubmed: 18362915
Leukemia. 2011 Jul;25(7):1174-81
pubmed: 21403648
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Biomed Pharmacother. 2019 May;113:108759
pubmed: 30856539
Biochem Pharmacol. 2016 Feb 1;101:87-99
pubmed: 26640276
Lab Invest. 2016 Oct;96(10):1076-86
pubmed: 27617398
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11115-20
pubmed: 23776235
Toxicol Appl Pharmacol. 2017 Feb 1;316:95-106
pubmed: 27913140
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
J Biol Chem. 2000 Mar 24;275(12):8432-8
pubmed: 10722677
Acta Biomater. 2021 Jul 1;128:462-473
pubmed: 33878476
Life Sci. 2005 Aug 5;77(12):1351-66
pubmed: 15913656
Chem Res Toxicol. 2008 Dec;21(12):2313-23
pubmed: 19548353
Arthritis Rheumatol. 2018 Nov;70(11):1732-1744
pubmed: 29855173
Curr Opin Genet Dev. 1999 Oct;9(5):580-7
pubmed: 10508688
J Nutr Biochem. 2019 Apr;66:1-16
pubmed: 30660832
Arthritis Rheum. 1996 Jan;39(1):115-24
pubmed: 8546720
Drug Metab Pharmacokinet. 2006 Aug;21(4):257-76
pubmed: 16946553
Int J Environ Res Public Health. 2019 Apr 06;16(7):
pubmed: 30959862
PLoS One. 2019 Jul 31;14(7):e0220451
pubmed: 31365547
Scand J Rheumatol. 2020 Nov;49(6):434-442
pubmed: 32856532
Genes Dev. 1999 Jan 1;13(1):20-5
pubmed: 9887096
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14222-7
pubmed: 21825138
EMBO J. 2017 Jan 4;36(1):116-128
pubmed: 27875245
Front Cell Dev Biol. 2020 Mar 13;8:131
pubmed: 32232043
Chem Res Toxicol. 2013 Apr 15;26(4):529-37
pubmed: 23432465
J Biol Chem. 1994 Nov 4;269(44):27337-43
pubmed: 7961644
Arthritis Rheum. 2010 May;62(5):1213-23
pubmed: 20213805
Nat Med. 2015 Jun;21(6):638-46
pubmed: 26005855
J Immunol. 2005 Dec 1;175(11):7348-56
pubmed: 16301641
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
Biochem Pharmacol. 2020 May;175:113905
pubmed: 32169417
Environ Int. 2015 Nov;84:26-38
pubmed: 26203892
J Biochem. 2000 Mar;127(3):503-9
pubmed: 10731723
Environ Pollut. 2017 Apr;223:305-310
pubmed: 28131481
Toxicol Lett. 2018 Aug;292:85-96
pubmed: 29689377
Sci Total Environ. 2021 Jun 25;775:145841
pubmed: 33621881
Biol Pharm Bull. 2004 Mar;27(3):407-10
pubmed: 14993811
Data Brief. 2019 Oct 15;27:104615
pubmed: 31871961
J Bone Miner Res. 2014 Apr;29(4):866-77
pubmed: 24115294
Bone. 2009 Mar;44(3):442-8
pubmed: 18977467
PLoS One. 2018 Dec 21;13(12):e0209690
pubmed: 30576387
Menopause. 2009 Jan-Feb;16(1):171-6
pubmed: 18779756
Scand J Immunol. 2017 Jun;85(6):441-449
pubmed: 28376277
J Agric Food Chem. 2019 Jun 19;67(24):6773-6784
pubmed: 31154759
Eur J Pharmacol. 2018 Jul 15;831:38-45
pubmed: 29715455
J Biol Chem. 1999 Oct 1;274(40):28708-15
pubmed: 10497241
Front Immunol. 2019 Mar 29;10:631
pubmed: 30984194
Chem Res Toxicol. 2006 Feb;19(2):288-94
pubmed: 16485905
Drug Discov Today. 2017 Jan;22(1):186-193
pubmed: 27554801
Biochem Pharmacol. 2018 May;151:47-58
pubmed: 29501585
J Biol Chem. 1992 Apr 5;267(10):6815-9
pubmed: 1313023
Front Immunol. 2018 Jan 08;8:1958
pubmed: 29375576
Nature. 2008 May 1;453(7191):106-9
pubmed: 18362914
J Immunol. 2003 Aug 15;171(4):1652-5
pubmed: 12902462
Int J Biol Sci. 2015 Jul 17;11(9):1113-26
pubmed: 26221077
Cell Res. 2008 Jun;18(6):605-8
pubmed: 18516065
J Clin Invest. 1985 Aug;76(2):789-800
pubmed: 3875632
J Immunol. 2014 Feb 15;192(4):1661-70
pubmed: 24403534
Phytother Res. 2019 Dec;33(12):3140-3152
pubmed: 31452288
Comp Biochem Physiol C Toxicol Pharmacol. 2016 Jan;179:125-36
pubmed: 26456929
Environ Sci Pollut Res Int. 2015 Nov;22(21):16962-8
pubmed: 26111752
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Oct 18;49(5):819-823
pubmed: 29045962
J Immunol. 2005 Oct 1;175(7):4184-8
pubmed: 16177056
Virchows Arch. 2002 Nov;441(5):415-27
pubmed: 12447670
Biochem Biophys Res Commun. 2008 Oct 24;375(3):331-5
pubmed: 18694728
Sci Total Environ. 2014 Jan 15;468-469:903-7
pubmed: 24080417
Immunity. 2018 Jan 16;48(1):19-33
pubmed: 29343438
Int J Mol Sci. 2017 Oct 17;18(10):
pubmed: 29039776
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13028-33
pubmed: 20615964
Clin Rheumatol. 2020 Mar;39(3):761-768
pubmed: 31729679
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136
Receptor. 1994 Winter;4(4):209-22
pubmed: 7894337

Auteurs

Xiaoyu Xi (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.

Qinbin Ye (Q)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.

Danping Fan (D)

Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.
Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.

Xiaoxue Cao (X)

Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.
Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.

Qiong Wang (Q)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.

Xing Wang (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.

Mengxiao Zhang (M)

Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.

Yuan Xu (Y)

Department of Traditional Chinese Medicine (TCM) Rheumatology, China-Japan Friendship Hospital, Beijing, China.

Cheng Xiao (C)

Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.
Department of Emergency, China-Japan Friendship Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH